Financial Statements ANNUAL REPORT AND ACCOUNTS 2015 Consolidated Statement of Comprehensive Loss For the year ended 31 December Note 2015 2014 $000 $000 Revenue 3 3,300 7,715 Operating expenses: Cost of revenue 4,5 3,925 5,416 Selling, general and administrative expenses 4,5 46,888 38,032 Research and development expenses 4,5 49,209 22,195 Operating loss 96,722 57,928 Finance income 7 723 545 Finance cost 7 53 323 Finance cost from IAS 39 fair value accounting 7 1,937 Finance cost income, net 1,267 222 Loss before taxation 97,989 57,706 Taxation Loss for the period 97,989 57,706 Other comprehensive loss: Items that may be reclassified subsequently to profit or loss: Foreign currency translation differences 46 159 Other comprehensive income loss, net of taxation 46 159 Total comprehensive loss 97,943 57,865 Loss attributable to: Equity holders of the parent 77,797 45,478 Non-controlling interests 17 20,192 12,228 97,989 57,706 Total comprehensive loss attributable to: Equity holders of the parent 77,752 45,637 Non-controlling interests 20,191 12,228 97,943 57,865 Loss per share $ $ Basic 8 0.36 0.24 Diluted 8 0.36 0.24 See accompanying notes to consolidated financial statements.
Page 107 of 165 030 c112021 5.5. indd 107 21 04 2016 13:27 ANNUAL REPORT AND ACCOUNTS 2015 Consolidated Statements of Financial Position As of 31 December Note 2015 2014 $000 $000 restated, see note 1 Non-current assets Property and equipment 9 34,173 16,330 Intangible assets 10 4,384 3,409 Investment in equity accounted investees 11 1,612 1,560 Other investments 12 51,545 22,176 Other financial assets 22 842 418 Other non-current assets 228 146 Total non-current assets 92,784 44,039 Current assets Cash and cash equivalents 13 105,555 224,075 Other investments 12 37,648 15,231 Inventories 14 1,511 2,919 Trade and other receivables 15 7,342 6,305 Subscription receivable 18 6,000 Other financial assets 22 371 461 Total current assets 158,427 248,991 Total assets 251,211 293,030 Equity Share capital 16 3,429 3,411 Share premium 16 155,867 153,442 Merger reserve 16 185,544 185,544 Translation reserve 16 16 61 Accumulated deficit 16 182,660 107,557 Equity attributable to owners of the Company 162,164 234,779 Non-controlling interests 16,17 20,790 4,946 Total equity 141,374 229,833 Non-current liabilities Deferred revenue 3 197 Loans 19 112 338 Other non-current liabilities 20 751 182 Total non-current liabilities 863 717 Current liabilities Trade and other payables 20 14,268 11,339 Deferred revenue 3 395 947 Loans 19 228 213 Subsidiary preferred shares 18 94,083 49,981 Total current liabilities 108,974 62,480 Total liabilities 109,837 63,197 Total equity and liabilities 251,211 293,030 See accompanying notes to consolidated financial statements.
Registered number: 8998697 The financial statements on pages 107 to 157 were approved by the Board of Directors and authorised for issue on 25 April 2016 and signed on its behalf by: Chris Silva Chief Executive Officer Page 108 of 165 030 c112021 5.5. indd 108 21 04 2016 13:27 Financial Statements ANNUAL REPORT AND ACCOUNTS 2015 Consolidated Statements of Changes in Equity For the year ended 31 December 2015 AccumuNonNote Share capital Share MergerTrans lation lated Total parentcontrol ling Total Shares Amount premium reserve reserve deficit equity interests equity $000 $000 $000 $000 $000 $000 $000 $000 Balance at 31 December 2013 157,463,790 2,445 185,544 98 70,834 117,253 2,606 119,859 Total comprehensive loss for the year Loss from continuing operations 45,478 45,478 12,228 57,706 Foreign currency translation 159 159 159 Total comprehensive loss for the year 159 45,478 45,637 12,228 57,865 Issuance of ordinary shares 16,17 48,164,365 818 142,243 143,061 143,061 New funds into non-controlling interest 16,17 4,492 4,492 Gain loss arising from change in non-controlling interest 17 184 184 184 Exercise of stock options 6 8,817,424 148 11,199 11,347 11,347 Equity-settled share based payments 6 8,939 8,939 8,939 Balance at 31 December 2014 restated, see note 1 214,445,579 3,411 153,442 185,544 61 107,557 234,779 4,946 229,833 Total comprehensive loss for the year Loss from continuing operations 77,797 77,797 20,192 97,989 Foreign currency translation 45 45 1 46 Total comprehensive loss for the year 45 77,797 77,752 20,191 97,943 Gain loss arising from change in non-controlling interest 17 3,228 3,228 3,228 Exercise of stock options 6 1,191,784 18 2,425 2,443 2,443 Equity-settled share based payments 6 5,922 5,922 1,119 7,041 Balance at 31 December 2015 215,637,363 3,429 155,867 185,544 16 182,660 162,164 20,790 141,374 See accompanying notes to consolidated financial statements.
Page 109 of 165 030 c112021 5.5. indd 109 21 04 2016 13:27 ANNUAL REPORT AND ACCOUNTS 2015 Consolidated Statements of Cash Flows For the year ended 31 December Note 2015 2014 $000 $000 Cash flows from operating activities: Net operating loss 96,722 57,928 Adjustments to reconcile net loss to net cash used in operating activities: Depreciation 9 3,339 2,312 Amortisation 10 747 580 Impairment losses on property and equipment 9 308 416 Impairment losses on intangible assets 10 1 1,063 Share-based compensation expense 5,6 7,041 8,939 Changes in working capital: Decrease increase in inventory 14 1,408 1,874 Increase in trade and other receivables 15 1,505 3,626 Increase in trade and other payables 20 2,929 6,301 Increase decrease in other non-current liabilities 20 569 96 Decrease in deferred revenue 3 749 1,686 Interest received 7 721 545 Interest paid 7 41 320 Other finance income cost 7 36 3 Net cash used in operating activities 81,918 45,377 Cash flows from investing activities: Purchases of property and equipment, net of disposals 9 21,490 1,217 Purchases of intangible assets, net of disposals 10 1,723 547 Purchases of investment in equity accounted investees 11 1,560 Purchases of other investments 12 51,786 37,407 Net cash used in investing activities 74,999 40,731 Cash flows from financing activities: Proceeds from exercise of stock options 16 2,443 11,347 Repayment of notes payable 19 211 3,249 Proceeds from issuance of share capital 16 143,061 Proceeds from issuance of share capital in subsidiaries 17 4,492 Proceeds from issuance of preferred shares in subsidiaries 18 36,165 49,981 Net cash provided by financing activities 38,397 205,632 Net decrease increase in cash and cash equivalents 118,520 119,524 Cash and cash equivalents at beginning of the period 224,075 104,551 Cash and cash equivalents at end of the period 105,555 224,075 Page 110 of 165 030 c112021 5.5. indd 110 21 04 2016 13:27
